SK Biopharmaceuticals Co., Ltd. (KRX:326030)

SK Biopharmaceuticals Revenue

SK Biopharmaceuticals had revenue of 176.28B KRW in the quarter ending June 30, 2025, with 31.55% growth. This brings the company's revenue in the last twelve months to 620.28B, up 33.38% year-over-year. In the year 2024, SK Biopharmaceuticals had annual revenue of 547.60B with 54.30% growth.

• Revenue (ttm): 620.28B
• Revenue Growth: +33.38%
• P/S Ratio: 12.57
• Revenue / Employee: 2.52B
• Employees: 246
• Market Cap: 7,800.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	547.60B	192.70B	54.30%
Dec 31, 2023	354.89B	108.71B	44.16%
Dec 31, 2022	246.18B	-172.47B	-41.20%
Dec 31, 2021	418.64B	392.65B	1,510.23%
Dec 31, 2020	26.00B	-97.85B	-79.01%